176 related articles for article (PubMed ID: 34743742)
21. Down-regulation of miRNA-452 is associated with adriamycin-resistance in breast cancer cells.
Hu Q; Gong JP; Li J; Zhong SL; Chen WX; Zhang JY; Ma TF; Ji H; Lv MM; Zhao JH; Tang JH
Asian Pac J Cancer Prev; 2014; 15(13):5137-42. PubMed ID: 25040964
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology.
Xu P; Wang L; Huang L; Li W; Lv S; Lv M; Ma J; Zhou Q; Wu X; Fu Z; Lu C; Yin H
Biomed Pharmacother; 2015 Oct; 75():173-8. PubMed ID: 26293775
[TBL] [Abstract][Full Text] [Related]
23. An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma.
Masuda M; Miki Y; Hata S; Takagi K; Sakurai M; Ono K; Suzuki K; Yang Y; Abe E; Hirakawa H; Ishida T; Suzuki T; Ohuchi N; Sasano H
J Transl Med; 2012 Sep; 10 Suppl 1(Suppl 1):S2. PubMed ID: 23227519
[TBL] [Abstract][Full Text] [Related]
24. MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.
Boo L; Ho WY; Ali NM; Yeap SK; Ky H; Chan KG; Yin WF; Satharasinghe DA; Liew WC; Tan SW; Ong HK; Cheong SK
Int J Biol Sci; 2016; 12(4):427-45. PubMed ID: 27019627
[TBL] [Abstract][Full Text] [Related]
25. Analysis of miRNA signature differentially expressed in exosomes from adriamycin-resistant and parental human breast cancer cells.
Chen WX; Xu LY; Qian Q; He X; Peng WT; Zhu YL; Cheng L
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30201690
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-452 contributes to the docetaxel resistance of breast cancer cells.
Hu Q; Chen WX; Zhong SL; Zhang JY; Ma TF; Ji H; Lv MM; Tang JH; Zhao JH
Tumour Biol; 2014 Jul; 35(7):6327-34. PubMed ID: 24648265
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.
Tormo E; Pineda B; Serna E; Guijarro A; Ribas G; Fores J; Chirivella E; Climent J; Lluch A; Eroles P
J Cell Biochem; 2015 Sep; 116(9):2061-73. PubMed ID: 25802200
[TBL] [Abstract][Full Text] [Related]
29. Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression.
Zhou S; Li J; Xu H; Zhang S; Chen X; Chen W; Yang S; Zhong S; Zhao J; Tang J
Gene; 2017 Jul; 622():1-12. PubMed ID: 28431975
[TBL] [Abstract][Full Text] [Related]
30. Determination of Usnic Acid Responsive miRNAs in Breast Cancer Cell Lines.
Kiliç N; Islakoğlu YÖ; Büyük İ; Gür-Dedeoğlu B; Cansaran-Duman D
Anticancer Agents Med Chem; 2019; 19(12):1463-1472. PubMed ID: 30417797
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
32. A chemogenomic approach to understand the antifungal action of Lichen-derived vulpinic acid.
Kwon Y; Cha J; Chiang J; Tran G; Giaever G; Nislow C; Hur JS; Kwak YS
J Appl Microbiol; 2016 Dec; 121(6):1580-1591. PubMed ID: 27660105
[TBL] [Abstract][Full Text] [Related]
33. Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells.
Yu X; Zhang X; Dhakal IB; Beggs M; Kadlubar S; Luo D
BMC Cancer; 2012 Jan; 12():29. PubMed ID: 22260523
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA expression profiling and bioinformatics analysis of dysregulated microRNAs in vinorelbine-resistant breast cancer cells.
Zhong S; Ma T; Zhang X; Lv M; Chen L; Tang J; Zhao J
Gene; 2015 Feb; 556(2):113-8. PubMed ID: 25445394
[TBL] [Abstract][Full Text] [Related]
35. Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.
Wang X; Zhu J
Thorac Cancer; 2018 Jun; 9(6):676-683. PubMed ID: 29697201
[TBL] [Abstract][Full Text] [Related]
36. miR-204 regulates the biological behavior of breast cancer MCF-7 cells by directly targeting FOXA1.
Shen SQ; Huang LS; Xiao XL; Zhu XF; Xiong DD; Cao XM; Wei KL; Chen G; Feng ZB
Oncol Rep; 2017 Jul; 38(1):368-376. PubMed ID: 28534958
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
[TBL] [Abstract][Full Text] [Related]
38. MiRNA-10b sponge: An anti-breast cancer study in vitro.
Liang AL; Zhang TT; Zhou N; Wu CY; Lin MH; Liu YJ
Oncol Rep; 2016 Apr; 35(4):1950-8. PubMed ID: 26820121
[TBL] [Abstract][Full Text] [Related]
39. Vulpinic acid, a lichen metabolite, emerges as a potential drug candidate in the therapy of oxidative stress-related diseases, such as atherosclerosis.
Sahin E; Dabagoglu Psav S; Avan I; Candan M; Sahinturk V; Koparal AT
Hum Exp Toxicol; 2019 Jun; 38(6):675-684. PubMed ID: 30868920
[TBL] [Abstract][Full Text] [Related]
40. β-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via Exosomes.
Zhang J; Zhang HD; Yao YF; Zhong SL; Zhao JH; Tang JH
Cell Physiol Biochem; 2015; 36(6):2274-86. PubMed ID: 26279432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
